Renal Cell Carcinoma

Molecular Targets and Clinical Applications, Second Edition

Nonfiction, Health & Well Being, Medical, Specialties, Radiology & Nuclear Medicine, Oncology
Cover of the book Renal Cell Carcinoma by , Humana Press
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781597453325
Publisher: Humana Press Publication: February 8, 2009
Imprint: Humana Language: English
Author:
ISBN: 9781597453325
Publisher: Humana Press
Publication: February 8, 2009
Imprint: Humana
Language: English

In the second edition of their critically acclaimed book, Ronald Bukowski, Robert Motzer, and Robert Figlin have thoroughly updated and expanded their survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. A panel of internationally renowned contributors explores the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors. The discussion includes the specific biology of selected target molecules or receptors and the various agents that inhibit these targets, including full chapters devoted to drugs that selectively inhibit receptor tyrosine kinases, such as sunitinib and axitinib. Further attention is paid to leading-edge strategies that target and inhibit tumor associated angiogenesis and block the vascular endothelial growth factor pathway. Comprehensive and authoritative, Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Second Edition is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by the pioneers of the field.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

In the second edition of their critically acclaimed book, Ronald Bukowski, Robert Motzer, and Robert Figlin have thoroughly updated and expanded their survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. A panel of internationally renowned contributors explores the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors. The discussion includes the specific biology of selected target molecules or receptors and the various agents that inhibit these targets, including full chapters devoted to drugs that selectively inhibit receptor tyrosine kinases, such as sunitinib and axitinib. Further attention is paid to leading-edge strategies that target and inhibit tumor associated angiogenesis and block the vascular endothelial growth factor pathway. Comprehensive and authoritative, Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Second Edition is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by the pioneers of the field.

More books from Humana Press

Cover of the book Modern Therapeutics in Rheumatic Diseases by
Cover of the book Hyperlipidemia in Primary Care by
Cover of the book Enzymatic Analysis by
Cover of the book Signaling Networks and Cell Cycle Control by
Cover of the book Surgical Treatment of Parkinson’s Disease and Other Movement Disorders by
Cover of the book Primary Central Nervous System Tumors by
Cover of the book Short Stay Management of Acute Heart Failure by
Cover of the book Clinical Handbook of Insomnia by
Cover of the book Dietary Supplements by
Cover of the book Studies on Cardiovascular Disorders by
Cover of the book A Primer for the Exercise and Nutrition Sciences by
Cover of the book A Song Out of Harlem by
Cover of the book Sexually Transmitted Diseases by
Cover of the book Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response by
Cover of the book Aging, Immunity, and Infection by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy